Inhibrx Biosciences, Inc. Profile Avatar - Palmy Investing

Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate tar…

Biotechnology
US, La Jolla [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
-100.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of INBX's Analysis
CIK: 1739614 CUSIP: 45720L107 ISIN: US45720L1070 LEI: - UEI: -
Secondary Listings
INBX has no secondary listings inside our databases.